Aterian ISIN: US02156U2006 Forum: Aktien Thema: Hauptdiskussion

Kranker Rücksetzer kurz vor Schluss. Ich glaube die kommt heute nochmal schön wieder hoch 🔮😁

Brutal 2. runde

Killer 😋

😃

👀

Aterian (Nasdaq: ATER) announced on Dec 8, 2025 that its Board has authorized a formal review to evaluate strategic alternatives to maximize shareholder value. The review may include a sale of assets, sale of the company, a business combination, merger or other strategic actions. The company said there are no assurances any transaction will result and no timetable has been set for completion. Aterian engaged A.G.P / Alliance Global Partners as financial advisor and Paul Hastings LLP as legal counsel to assist with the review. Management emphasized ongoing customer and partner service during the process.